Cargando…
Repeated Low-Dose Streptozotocin and Alloxan Induced Long-Term and Stable Type 1 Diabetes Model in Beagle Dogs
Type 1 diabetes mellitus (T1DM) is a chronic disease represented by insulin-causing pancreatic β-cell disruption and hyperglycemia. Therefore, it is necessary to establish a variety of animal models of diabetes to study the pathogenesis and pathophysiology of it. However, there are few reports on th...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9377912/ https://www.ncbi.nlm.nih.gov/pubmed/35978645 http://dx.doi.org/10.1155/2022/5422287 |
_version_ | 1784768434291081216 |
---|---|
author | Han, Qingyue Sun, Jie Xie, Wenting Bai, Yuman Wang, Shuzhou Huang, Jianjia Zhou, Shuilian Li, Quanwei Zhang, Hui Tang, Zhaoxin |
author_facet | Han, Qingyue Sun, Jie Xie, Wenting Bai, Yuman Wang, Shuzhou Huang, Jianjia Zhou, Shuilian Li, Quanwei Zhang, Hui Tang, Zhaoxin |
author_sort | Han, Qingyue |
collection | PubMed |
description | Type 1 diabetes mellitus (T1DM) is a chronic disease represented by insulin-causing pancreatic β-cell disruption and hyperglycemia. Therefore, it is necessary to establish a variety of animal models of diabetes to study the pathogenesis and pathophysiology of it. However, there are few reports on the use of beagle dogs to establish an animal model of type 1 diabetes. This study aimed to explore a simple and feasible modeling method to establish a long-term and stable type 1 diabetes model in beagle dogs. Forty adult beagle dogs were randomly divided into control group and model group. After 24 h of fasting, streptozotocin (20 mg/kg) and alloxan (20 mg/kg) were injected through the cephalic vein. The second intravenous injection was given on the 4th day after the first injection. Insulin release testing was performed on the 7th day after the last intravenous injection. Fasting blood glucose and body weight were recorded monthly. Four months after the last injection, the serum fructosamine content and the ratio of glycated hemoglobin were detected. Then, the pancreatic tissue was harvested for histopathological examination. The results showed that the level of fasting blood glucose of the 16 dogs in the model group was consistently higher than 11.1 mmol/L for 4 consecutive months. Moreover, compared with the control group, the insulin release curve of the model group was flat with no increase. The body weight of the model group was significantly reduced, and the ratios of blood glucose, fructosamine, and glycosylated hemoglobin were significantly higher than those in the control group. Meanwhile, histopathological examination of the pancreas showed that the islet beta cells appeared to have vacuoles or even necrosis. In the model group, pancreatic β-cells were damaged and insulin release was reduced. These results suggest that the above modeling methods can induce long-term and stable type 1 diabetes models in beagle dogs. |
format | Online Article Text |
id | pubmed-9377912 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-93779122022-08-16 Repeated Low-Dose Streptozotocin and Alloxan Induced Long-Term and Stable Type 1 Diabetes Model in Beagle Dogs Han, Qingyue Sun, Jie Xie, Wenting Bai, Yuman Wang, Shuzhou Huang, Jianjia Zhou, Shuilian Li, Quanwei Zhang, Hui Tang, Zhaoxin Biomed Res Int Research Article Type 1 diabetes mellitus (T1DM) is a chronic disease represented by insulin-causing pancreatic β-cell disruption and hyperglycemia. Therefore, it is necessary to establish a variety of animal models of diabetes to study the pathogenesis and pathophysiology of it. However, there are few reports on the use of beagle dogs to establish an animal model of type 1 diabetes. This study aimed to explore a simple and feasible modeling method to establish a long-term and stable type 1 diabetes model in beagle dogs. Forty adult beagle dogs were randomly divided into control group and model group. After 24 h of fasting, streptozotocin (20 mg/kg) and alloxan (20 mg/kg) were injected through the cephalic vein. The second intravenous injection was given on the 4th day after the first injection. Insulin release testing was performed on the 7th day after the last intravenous injection. Fasting blood glucose and body weight were recorded monthly. Four months after the last injection, the serum fructosamine content and the ratio of glycated hemoglobin were detected. Then, the pancreatic tissue was harvested for histopathological examination. The results showed that the level of fasting blood glucose of the 16 dogs in the model group was consistently higher than 11.1 mmol/L for 4 consecutive months. Moreover, compared with the control group, the insulin release curve of the model group was flat with no increase. The body weight of the model group was significantly reduced, and the ratios of blood glucose, fructosamine, and glycosylated hemoglobin were significantly higher than those in the control group. Meanwhile, histopathological examination of the pancreas showed that the islet beta cells appeared to have vacuoles or even necrosis. In the model group, pancreatic β-cells were damaged and insulin release was reduced. These results suggest that the above modeling methods can induce long-term and stable type 1 diabetes models in beagle dogs. Hindawi 2022-08-08 /pmc/articles/PMC9377912/ /pubmed/35978645 http://dx.doi.org/10.1155/2022/5422287 Text en Copyright © 2022 Qingyue Han et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Han, Qingyue Sun, Jie Xie, Wenting Bai, Yuman Wang, Shuzhou Huang, Jianjia Zhou, Shuilian Li, Quanwei Zhang, Hui Tang, Zhaoxin Repeated Low-Dose Streptozotocin and Alloxan Induced Long-Term and Stable Type 1 Diabetes Model in Beagle Dogs |
title | Repeated Low-Dose Streptozotocin and Alloxan Induced Long-Term and Stable Type 1 Diabetes Model in Beagle Dogs |
title_full | Repeated Low-Dose Streptozotocin and Alloxan Induced Long-Term and Stable Type 1 Diabetes Model in Beagle Dogs |
title_fullStr | Repeated Low-Dose Streptozotocin and Alloxan Induced Long-Term and Stable Type 1 Diabetes Model in Beagle Dogs |
title_full_unstemmed | Repeated Low-Dose Streptozotocin and Alloxan Induced Long-Term and Stable Type 1 Diabetes Model in Beagle Dogs |
title_short | Repeated Low-Dose Streptozotocin and Alloxan Induced Long-Term and Stable Type 1 Diabetes Model in Beagle Dogs |
title_sort | repeated low-dose streptozotocin and alloxan induced long-term and stable type 1 diabetes model in beagle dogs |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9377912/ https://www.ncbi.nlm.nih.gov/pubmed/35978645 http://dx.doi.org/10.1155/2022/5422287 |
work_keys_str_mv | AT hanqingyue repeatedlowdosestreptozotocinandalloxaninducedlongtermandstabletype1diabetesmodelinbeagledogs AT sunjie repeatedlowdosestreptozotocinandalloxaninducedlongtermandstabletype1diabetesmodelinbeagledogs AT xiewenting repeatedlowdosestreptozotocinandalloxaninducedlongtermandstabletype1diabetesmodelinbeagledogs AT baiyuman repeatedlowdosestreptozotocinandalloxaninducedlongtermandstabletype1diabetesmodelinbeagledogs AT wangshuzhou repeatedlowdosestreptozotocinandalloxaninducedlongtermandstabletype1diabetesmodelinbeagledogs AT huangjianjia repeatedlowdosestreptozotocinandalloxaninducedlongtermandstabletype1diabetesmodelinbeagledogs AT zhoushuilian repeatedlowdosestreptozotocinandalloxaninducedlongtermandstabletype1diabetesmodelinbeagledogs AT liquanwei repeatedlowdosestreptozotocinandalloxaninducedlongtermandstabletype1diabetesmodelinbeagledogs AT zhanghui repeatedlowdosestreptozotocinandalloxaninducedlongtermandstabletype1diabetesmodelinbeagledogs AT tangzhaoxin repeatedlowdosestreptozotocinandalloxaninducedlongtermandstabletype1diabetesmodelinbeagledogs |